Company / Book Value per Share
Vera Therapeutics, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$9.411
FY2025
5-year range
$2.381 / $10.432
FY2021-FY2025
Trend
-9.8%
vs FY2024
Sector context
#61 of 209
Health Care
What the data says
At $9.411, Vera Therapeutics, Inc.'s book value per share ranks #61 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 6 years, ranging from -$279.245 in FY2020 to $10.432 in FY2024.
Based on SEC 10-K filings.
$9.411 in FY2025 with a 3-year CAGR of +48.1%.
Improved from $2.381 to $9.411 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +48.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 209 in Health CareTop 29% of 209This company $9.411 Sector average $189.406
▼
-95.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +48.1%, indicating consistent growth.
- In FY2025, book value per share decreased 9.8% year-over-year.
- Ranks #61 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.411 | -9.8% |
| FY2024 | $10.432 | +338.1% |
| FY2023 | $2.381 | -17.7% |
| FY2022 | $2.894 | -44.1% |
| FY2021 | $5.18 | +101.9% |
| FY2020 | -$279.245 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026